These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25540021)

  • 1. A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases.
    Neuwirt H; Perco P; Kainz A; Mühlberger I; Leierer J; Braniff SJ; Mayer B; Mayer G; Rudnicki M
    BMC Med Genomics; 2014 Dec; 7():75. PubMed ID: 25540021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies.
    Rudnicki M; Eder S; Perco P; Enrich J; Scheiber K; Koppelstätter C; Schratzberger G; Mayer B; Oberbauer R; Meyer TW; Mayer G
    Kidney Int; 2007 Feb; 71(4):325-35. PubMed ID: 17183245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease.
    Rossi G; Giordano A; Breda S; Lisi C; Roura X; Zatelli A; Paltrinieri S
    Vet J; 2013 Oct; 198(1):109-15. PubMed ID: 23899407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased renal versican expression is associated with progression of chronic kidney disease.
    Rudnicki M; Perco P; Neuwirt H; Noppert SJ; Leierer J; Sunzenauer J; Eder S; Zoja C; Eller K; Rosenkranz AR; Müller GA; Mayer B; Mayer G
    PLoS One; 2012; 7(9):e44891. PubMed ID: 23024773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of urinary vascular endothelial growth factor (VEGF) on worsening kidney function in proteinuric chronic kidney disease.
    Avguštin N; Rotar Ž; Pajek J; Kovač D; Osredkar J; Lindič J
    Clin Nephrol; 2017 Supplement 1; 88(13):10-13. PubMed ID: 28601119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein-7 and disease progression in renal amyloidosis patients.
    Denizli N; Azak A; Şakacı M; Huddam B; Koçak G; Akdoğan MF; Demirci R; Gücün M; Ortabozkoyun L; Fidan Y; Akdağ İ; Duranay M
    Ren Fail; 2013 Sep; 35(8):1112-5. PubMed ID: 23902471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.
    Zhang T; Chen H; Liang S; Chen D; Zheng C; Zeng C; Zhang H; Liu Z
    PLoS One; 2014; 9(11):e111992. PubMed ID: 25372665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
    Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
    Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
    Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study.
    Tonelli M; Muntner P; Lloyd A; Manns BJ; James MT; Klarenbach S; Quinn RR; Wiebe N; Hemmelgarn BR;
    Ann Intern Med; 2011 Jan; 154(1):12-21. PubMed ID: 21200034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma.
    Haddad AQ; Kapur P; Singla N; Raman JD; Then MT; Nuhn P; Buchner A; Bastian P; Seitz C; Shariat SF; Bensalah K; Rioux-Leclercq N; Sagalowsky A; Lotan Y; Margulis V
    Cancer; 2015 Jan; 121(1):43-50. PubMed ID: 25186283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
    Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
    Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
    Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function changes after snorkel/chimney repair of juxtarenal aneurysms.
    Lee JT; Varu VN; Tran K; Dalman RL
    J Vasc Surg; 2014 Sep; 60(3):563-70. PubMed ID: 24785683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.